Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/20/2014EP2767279A1 Erythropoietin production-promoting agent
08/20/2014EP2767278A1 Enhancer of survival of transplanted organ
08/20/2014EP2767277A1 Treatment agent and/or prophylactic agent for side effects of cancer drugs
08/20/2014EP2767276A1 Improving / prophylactic agent for chronic kidney disease
08/20/2014EP2767275A1 Nortriptyline, haloperidol or prochlorperazine edisylate for use in the treatment of tuberculosis as well as two screening methods
08/20/2014EP2767274A1 Carotenoid-containing composition and method for producing same
08/20/2014EP2767273A1 Death-associated protein kinases, inhibitors and activators thereof for use in pharmaceutical compositions and in predictive medicine
08/20/2014EP2767272A1 Solid pharmaceutical dosage form of dolutegravir
08/20/2014EP2767175A1 Nutrition with lipids and non-digestible saccharides
08/20/2014EP2767174A1 Oral compositions
08/20/2014EP2767173A1 Use of human milk oligosaccharides in infant nutrition
08/20/2014EP2767163A1 Transmucosal administration of drug compositions for treating and preventing disorders in animals
08/20/2014EP2766495A1 Method of diagnosis, prognostic or treatment of neurodegenerative diseases
08/20/2014EP2766481A1 Targeting of mirna precursors
08/20/2014EP2766479A1 Tricyclo-phosphorothioate dna
08/20/2014EP2766424A1 Synthesis of an injectable multiphasic gel containing free and cross-linked monophasic hyaluronic acid and biphasic hyaluronic acid combined with hydroxyapatite with microencapsulated hyaluronidase inhibitor.
08/20/2014EP2766380A1 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
08/20/2014EP2766373A1 Sila analogs of oxazolidinone derivatives and synthesis thereof
08/20/2014EP2766370A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
08/20/2014EP2766369A2 Novel salts of sitagliptin, process for the preparation and pharmaceutical composition thereof
08/20/2014EP2766368A1 5,7-substituted-imidazo[1,2-c]pyrimidines
08/20/2014EP2766367A1 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and their use as antiviral active substances
08/20/2014EP2766366A1 Tetrahydrotriazolopyrimidine derivatives as human neutrophil elastase inhibitors
08/20/2014EP2766365A1 Antiviral compounds
08/20/2014EP2766364A1 Folate conjugates of albumin-binding entities
08/20/2014EP2766363A1 Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions containing them
08/20/2014EP2766361A1 8 - carbamoyl - 2 - (2,3- di substituted pyrid - 6 - yl) -1,2,3,4 -tetrahydroisoquinoline derivatives as apoptosis - inducing agents for the treatment of cancer and immune and autoimmune diseases
08/20/2014EP2766360A1 Soluble guanylate cyclase activators
08/20/2014EP2766359A2 Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
08/20/2014EP2766358A1 Novel oxazine derivatives and their use in the treatment of disease
08/20/2014EP2766357A2 Meso-biliverdin compositions and methods
08/20/2014EP2766356A1 Quinazoline derivatives as kinases inhibitors and methods of use thereof
08/20/2014EP2766355A2 Pyrazol-3-ones that activate pro-apoptotic bax
08/20/2014EP2766354A1 Protein kinase inhibitors
08/20/2014EP2766353A1 2-oxo-piperidinyl derivatives
08/20/2014EP2766352A1 Indazole compounds as kinase inhibitors and method of treating cancer with same
08/20/2014EP2766350A1 Selective androgen receptor modulators
08/20/2014EP2766349A1 Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
08/20/2014EP2766348A1 Benzodioxepin-3-one compounds as dyes or as fluorescent emitters
08/20/2014EP2766347A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/20/2014EP2766346A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/20/2014EP2766345A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/20/2014EP2766344A1 Ep1 receptor ligands
08/20/2014EP2766339A1 The use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain
08/20/2014EP2766041A1 Combinatorial compositions and methods of treating hemoglobinopathies
08/20/2014EP2766039A1 Compositions for the treatment of rheumatoid arthritis and methods of using same
08/20/2014EP2766029A1 Treatment of degenerative joint disease
08/20/2014EP2766025A1 Therapeutic sulfated polysaccharides, compositions thereof, and methods for treating patients
08/20/2014EP2766024A1 Total synthesis and immunological evaluation of saccharide moieties of the lipopolysaccharide from neisseria meningitidis
08/20/2014EP2766023A1 Use of a composition comprising a poly-organosiloxane
08/20/2014EP2766022A1 Cannabinoid-2-receptor agonists
08/20/2014EP2766021A1 Compounds for the treatment of hepatitis c
08/20/2014EP2766020A1 Treatment of multiple sclerosis with combination of laquinimod and fingolimod
08/20/2014EP2766019A1 Anti-inflammatory compounds
08/20/2014EP2766017A1 Methods for treating a stroke-related sensorimotor impairment using aminopyridines
08/20/2014EP2766016A1 Improved sperm function/activity
08/20/2014EP2766015A1 2-carboxamide cycloamino urea derivatives in combination with hsp90 inhibitors for the treatment of proliferative diseases
08/20/2014EP2766014A1 Methods of treating pediatric patients using dexmedetomidine
08/20/2014EP2766013A2 Method for treating thrombotic disorders using quercetin-containing compositions
08/20/2014EP2766012A2 Compositions useful in treating nephropathy and methods for preparation of same
08/20/2014EP2766011A1 Treatment of pharmacological-induced hypochlorhydria
08/20/2014EP2766010A1 Inhibitor of colonisation of mucosa
08/20/2014EP2766009A1 Method and compositions for treating skin
08/20/2014EP2766008A1 Composition for nasal application with improved stability
08/20/2014EP2766007A1 Rasagiline citramide
08/20/2014EP2766006A1 Compositions comprising salbutamol sulphate
08/20/2014EP2766005A1 Compositions comprising salbutamol sulphate
08/20/2014EP2766004A1 R(+)-n-methyl-propargyl-aminoindan
08/20/2014EP2766003A1 Composition for the prophylactic treatment of neuropathic pain
08/20/2014EP2766002A2 R(+)-n-formyl-propargyl-aminoindan
08/20/2014EP2766001A1 Buffered oxygen therapeutic
08/20/2014EP2766000A2 Scd1 antagonists for treating cancer
08/20/2014EP2765997A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
08/20/2014EP2765993A1 Formulations of cyclopropanecarboxylic acid {2-(1s)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amidecelgene corporation state of incorporation:delaware
08/20/2014EP2765992A1 Foam formulations
08/20/2014EP2765990A2 Solid dispersion
08/20/2014EP2765989A1 Methods and compositions for rapid transbuccal delivery of active agents
08/20/2014EP2765987A1 Compositions for the treatment of dry eye
08/20/2014EP2765986A1 Prevention and treatment of ocular conditions
08/20/2014EP2765985A1 Orally dispersible tablet
08/20/2014EP2765983A1 Composition for introducing nucleic acids into cells
08/20/2014EP2765982A1 Dimethyl sulfoxide as solvent for nucleic acids
08/20/2014EP2765873A1 Accelerating muscle recovery after immobilization-induced muscle atrophy
08/19/2014US8809584 N-substituted-N-phenylethylsulfonamides for the identification of biological and pharmacological activity
08/19/2014US8809562 Use of metallocene compounds for cancer treatment
08/19/2014US8809560 Trans-, trans-conjugated linoleic acid compositions and use thereof
08/19/2014US8809555 Anti-leishmanial compound and anti-leishmanial drug
08/19/2014US8809552 Azetidine compounds, compositions and methods of use
08/19/2014US8809550 Androgen receptor antagonists and uses thereof
08/19/2014US8809549 Esters of bendamustine and related compounds, and medical use thereof
08/19/2014US8809548 Hepatitis C virus inhibitors
08/19/2014US8809542 Salts of benzimidazole compound and use thereof
08/19/2014US8809541 Heterocyclic compound, and composition for treating inflammatory diseases using same
08/19/2014US8809540 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
08/19/2014US8809539 Dicarboxylic acid derivatives as S1P1 receptor agonists
08/19/2014US8809538 Piperidine-containing compounds and use thereof
08/19/2014US8809537 N-ethyl-4-hydroxyl-1-methyl-5-(methyl(2,3,4,5,6-pentahydroxyhexyl)amino)-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide
08/19/2014US8809534 Compounds as tyrosine kinase modulators
08/19/2014US8809532 Aza-ring fused indole and indoline derivatives
08/19/2014US8809530 Compositions of protein receptor tyrosine kinase inhibitors
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 7860